COMBITAZ 1G+125MG INJECTION is used in the treatment of serious bacterial infections, including those caused by resistant organisms in hospital settings. The detailed uses of COMBITAZ 1G+125MG INJECTION are as follows:&lt;br/&gt;&bull; Treats respiratory infections: COMBITAZ 1G+125MG INJECTION is effective in managing severe pneumonia, including hospital-acquired cases.&lt;br/&gt;&bull; Manages urinary tract infections: COMBITAZ 1G+125MG INJECTION is used for complicated UTIs, especially those involving resistant bacterial strains.&lt;br/&gt;&bull; Controls skin and soft tissue infections: COMBITAZ 1G+125MG INJECTION is indicated for cellulitis, infected wounds, and abscesses.&lt;br/&gt;&bull; Treats intra-abdominal infections: COMBITAZ 1G+125MG INJECTION is useful in the treatment of serious abdominal infections such as peritonitis.&lt;br/&gt;&bull; Effective against hospital-acquired infections: COMBITAZ 1G+125MG INJECTION acts against multidrug-resistant bacteria, including ESBL-producing organisms commonly found in hospital settings.&lt;br/&gt;&bull; Enhances antibacterial action: COMBITAZ 1G+125MG INJECTION provides a synergistic effect by inhibiting bacterial enzymes that break down antibiotics, thereby enhancing overall antibacterial activity against a wide range of gram-positive and gram-negative organisms.&lt;br/&gt;

Medicinal Benefits:

COMBITAZ 1G+125MG INJECTION contains Ceftazidime and Tazobactam. Ceftazidime works by interfering with the production of the bacterial cell wall (a protective covering required for survival). Tazobactam reduces bacterial resistance and increases the action of Ceftazidime against bacteria. Together, they aid in the treatment of bacterial infections, including serious, life-threatening infections due to gram-positive bacteria.

FAQs

What is the use of COMBITAZ 1G+125MG INJECTION?

COMBITAZ 1G+125MG INJECTION is used to treat Bacterial infections.

How does COMBITAZ 1G+125MG INJECTION work?

Ceftazidime and Tazobactam are both present in COMBITAZ 1G+125MG INJECTION. Ceftazidime works by preventing the production of the bacterial cell wall (a protective covering required for survival). Tazobactam reduces bacterial resistance while increasing the efficacy of Ceftazidime against bacteria. Together, COMBITAZ 1G+125MG INJECTION aids in the treatment of bacterial illnesses.

Does COMBITAZ 1G+125MG INJECTION affect laboratory test results?

COMBITAZ 1G+125MG INJECTION may Increase liver enzymes. Therefore, if you are about to undergo any laboratory tests, inform your doctor or lab technician that you are taking COMBITAZ 1G+125MG INJECTION.

Does COMBITAZ 1G+125MG INJECTION cause diarrhoea?

COMBITAZ 1G+125MG INJECTION may cause diarrhoea as a common side effect. However, if the condition persists or worsens, consult a doctor immediately.

Is it ideal to take vaccination while on COMBITAZ 1G+125MG INJECTION therapy?

If you are being treated with COMBITAZ 1G+125MG INJECTION or have been treated within the last three days, you should talk to your doctor before taking the vaccine. Antibiotics like COMBITAZ 1G+125MG INJECTION can reduce the vaccine's activity.

How long does COMBITAZ 1G+125MG INJECTION takes to work?

COMBITAZ 1G+125MG INJECTION usually begins to work shortly after you start taking it. However, it may take a few days to eliminate all harmful bacteria and improve your symptoms.

What if I don't get better after using COMBITAZ 1G+125MG INJECTION?

If you do not get better after using COMBITAZ 1G+125MG INJECTION, reach out to your doctor immediately. They might re-evaluate your condition, investigate potential issues, and modify your treatment accordingly.

What are the side effects of COMBITAZ 1G+125MG INJECTION?

COMBITAZ 1G+125MG INJECTION causes side effects such as headache, dizziness, nausea, vomiting, diarrhoea, abdominal pain, muscle spasm, and elevated liver enzymes. Contact a doctor if these side effects persist for longer durations.